Skip to main content

Table 3 Characteristics of interview participants (n = 36)

From: The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia

  

Number of participants

Age group

  
 

18–29 years

1

 

30–39 years

5

 

40–49 years

8

 

50–59 years

14

 

60 years and over

8

Sex

  
 

Male

13

 

Female

23

Stakeholder group

  
 

Rheumatologist

8

 

Patient

6

 

Government advisor

5

 

Public servant

8

 

Consumer representative

5

 

Pharmaceutical industry representative

3

 

Clinical nurse

1